Filing Details

Accession Number:
0001209191-14-031257
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-05 19:10:09
Reporting Period:
2014-05-01
Filing Date:
2014-05-05
Accepted Time:
2014-05-05 18:10:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520697 Acadia Healthcare Company Inc. ACHC Services-Specialty Outpatient Facilities, Nec (8093) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1337573 L Christopher Howard Acadia Healthcare Company, Inc.
830 Crescent Centre Drive, Suite 610
Franklin TN 37067
Evp, Gc And Secretary No Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-05-01 9,068 $40.67 238,001 No 4 S Direct
Common Stock Acquisiton 2014-05-02 6,464 $15.96 244,465 No 4 M Direct
Common Stock Disposition 2014-05-02 3,996 $41.46 240,469 No 4 F Direct
Common Stock Disposition 2014-05-02 2,468 $41.11 238,001 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2014-05-02 6,464 $0.00 6,464 $15.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,930 2014-03-19 2022-03-19 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2014.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.0000 to $41.7000, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of the Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.0500 to $41.9800, inclusive.